Skip to content

Advertisement

  • Erratum
  • Open Access

Erratum to: The B-VITAGE trial: A randomized trial of homocysteine lowering treatment of depression in later life

  • 1, 2, 3,
  • 1, 4, 5,
  • 1,
  • 6, 7,
  • 1, 2,
  • 1, 2,
  • 3 and
  • 1, 2, 3Email author
Trials201112:193

https://doi.org/10.1186/1745-6215-12-193

Received: 13 July 2011

Accepted: 16 August 2011

Published: 16 August 2011

The original article was published in Trials 2010 11:8

Correction

Following the publication of our article [1], we noticed an error regarding the dosage of vitamin B12. In the manuscript, we reported that the daily dosage of vitamin B12 would be 0.4 mg, when in fact the dosage of vitamin B12 used in the B-VITAGE trial is 0.5 mg per day.

In the abstract:

The B-VITAGE trial is a 12-month randomized, double-blind, placebo-controlled trial of daily citalopram (20 to 40 mg) plus B12(0.4 mg), B6 (25 mg) and folic acid (2 mg) or citalopram (20 to 40 mg) plus placebo for the treatment of depression in later life.

Should read

The B-VITAGE trial is a 12-month randomized, double-blind, placebo-controlled trial of daily citalopram (20 to 40 mg) plus B12(0.5 mg), B6 (25 mg) and folic acid (2 mg) or citalopram (20 to 40 mg) plus placebo for the treatment of depression in later life.

In the "Intervention and Blinding" section:

Eligible participants will be randomly allocated to treatment with citalopram plus 400 μg vitamin B12, 2 mg folic acid and 25 mg B6 or citalopram plus placebo.

Should read

Eligible participants will be randomly allocated to treatment with citalopram plus 500 μg vitamin B12, 2 mg folic acid and 25 mg B6 or citalopram plus placebo.

Notes

Authors’ Affiliations

(1)
Western Australian Centre for Health & Ageing, Centre for Medical Research, University of Western Australia, Perth, Australia
(2)
School of Psychiatry & Clinical Neurosciences, University of Western Australia, Perth, Australia
(3)
Department of Psychiatry, Royal Perth Hospital, Perth, Australia
(4)
School of Medicine & Pharmacology, University of Western Australia, Perth, Australia
(5)
Department of Geriatric Medicine, Royal Perth Hospital, Perth, Australia
(6)
School of Pathology & Laboratory Medicine, University of Western Australia, Perth, Australia
(7)
Department of Biochemistry, Royal Perth Hospital, Perth, Australia

References

  1. Ford AH, Flicker L, McCaul K, van Bockxmeer F, Hegarty S, Hirani V, Fenner S, Almeida OP: The B-VITAGE trial: A randomized trial of homocysteine lowering treatment of depression in later life. Trials. 2010, 11: 8-10.1186/1745-6215-11-8.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© Ford et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.

Advertisement